Author details

Full Name

Mirra Chung

Affiliation

ORCID

Career Start Year

1994

Papers

H Index

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
37542042	Proteomic profiling across breast cancer cell lines and models.	Sci Data	2023
37069550	Three tyrosine kinase inhibitors cause cardiotoxicity by inducing endoplasmic reticulum stress and inflammation in cardiomyocytes.		2023
35292783	Temporal and spatial topography of cell proliferation in cancer.	Nature Cell Biology	2022
36376301	Multiplexed and reproducible high content screening of live and fixed cells using Dye Drop.	Nat Commun	2022
36207580	A multi-omic analysis of MCF10A cells provides a resource for integrative assessment of ligand-mediated molecular and phenotypic responses.	Commun Biol	2022
33893219	Continuous Monitoring of Tau-Induced Neurotoxicity in Patient-Derived iPSC-Neurons.	J Neurosci	2021
31812693	Torin2 Exploits Replication and Checkpoint Vulnerabilities to Cause Death of PI3K-Activated Triple-Negative Breast Cancer Cells.	Cell Syst	2020
31735695	Development and Characterization of a Wee1 Kinase Degrader.	Cell Chem Biol	2020
32388561	TheÂ Alzheimer Disease-Causing Presenilin-1 L435F Mutation Causes Increased Production of Soluble AÎ²43 Species in Patient-Derived iPSC-Neurons, Closely Mimicking Matched Patient Brain Tissue.	J Neuropathol Exp Neurol	2020
31178407	Multiomics Profiling Establishes the Polypharmacology of FDA-Approved CDK4/6 Inhibitors and the Potential for Differential Clinical Activity.	Cell Chem Biol	2019
31302153	A Multi-center Study on the Reproducibility of Drug-Response Assays in Mammalian Cell Lines.	Cell Syst	2019
29084964	Common and cell-type specific responses to anti-cancer drugs revealed by high throughput transcript profiling.	Nat Commun	2017
28628199	Measuring Cancer Drug Sensitivity and Resistance in Cultured Cells.	Curr Protoc Chem Biol	2017
27135972	Growth rate inhibition metrics correct for confounders in measuring sensitivity to cancer drugs.	Nat Methods	2016
24931167	An intergenic regulatory region mediates Drosophila Myc-induced apoptosis and blocks tissue hyperplasia.	Oncogene	2015
25924716	An intergenic regulatory region mediates Drosophila Myc-induced apoptosis and blocks tissue hyperplasia.	Oncogene	2015
24655548	Analysis of growth factor signaling in genetically diverse breast cancer lines.	BMC Biol	2014
24065145	Profiles of Basal and stimulated receptor signaling networks predict drug response in breast cancer lines.	Sci Signal	2013
21698184	Mice with a targeted deletion of the type 2 deiodinase are insulin resistant and susceptible to diet induced obesity.	PLoS ONE	2011
19651899	The E3 ubiquitin ligase TEB4 mediates degradation of type 2 iodothyronine deiodinase.	Molecular and Cellular Biology	2009
16037131	Transforming growth factor-beta promotes inactivation of extracellular thyroid hormones via transcriptional stimulation of type 3 iodothyronine deiodinase.	Molecular Endocrinology	2005
12667458	Coupled tRNA(Sec)-dependent assembly of the selenocysteine decoding apparatus.	Molecular Cell	2003
10196184	Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells.	J Biol Chem	1999
9566879	Alternative splicing variants of IkappaB beta establish differential NF-kappaB signal responsiveness in human cells.	Molecular and Cellular Biology	1998
9452433	IkappaBbeta interacts with the retinoid X receptor and inhibits retinoid-dependent transactivation in lipopolysaccharide-treated cells.	Journal of Biological Chemistry	1998
9295294	Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR.	Journal of Biological Chemistry	1997
9372944	Novel receptor interaction and repression domains in the orphan receptor SHP.	Molecular and Cellular Biology	1997
7997240	A new orphan member of the nuclear hormone receptor superfamily closely related to Rev-Erb.	Molecular Endocrinology	1994